A survey of genomic traces reveals a common sequencing error, RNA editing, and DNA editing

PLoS Genetics

Volumn 6, Issue 5, 2010, Pages 8-

  Zaranek, Alexander Wait ^a   Levanon, Erez Y ^a,b   Zecharia, Tomer ^c   Clegg, Tom ^d   Church, George M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

^c Compugen Ltd ^*  (Israel)

^d Scalable Computing Experts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE THAT ACTS ON RNA; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; GENOMIC DNA; HYDROLASE; UNCLASSIFIED DRUG; APOBEC3 PROTEIN, HUMAN; CYTOSINE DEAMINASE; DNA; DSRNA ADENOSINE DEAMINASE;

ACCURACY; ARTICLE; BASE MISPAIRING; CONTROLLED STUDY; DNA EDITING; DNA STRUCTURE; ERROR; GENE CLUSTER; GENE MAPPING; GENE SEQUENCE; GENETIC DATABASE; HAPLOTYPE MAP; HUMAN; MOUSE; NONHUMAN; RNA EDITING; GENETICS; GENOMICS; MULTIGENE FAMILY;

XENOPUS TROPICALIS;

ADENOSINE DEAMINASE; BASE PAIR MISMATCH; CYTOSINE DEAMINASE; DNA; GENOMICS; HUMANS; MULTIGENE FAMILY; RNA EDITING;

EID: 77953180687     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1000954     Document Type: Article

References (51)

1. Bass BL (2002) RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71: 817-846.
2. Hurst SR, Hough RF, Aruscavage PJ, Bass BL (1995) Deamination of mammalian glutamate receptor RNA by Xenopus dsRNA adenosine deaminase: similarities to in vivo RNA editing. Rna 1: 1051-1060.
3. Kim U, Wang Y, Sanford T, Zeng Y, Nishikura K (1994) Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc Natl Acad Sci U S A 91: 11457-11461.
4. Melcher T, Maas S, Herb A, Sprengel R, Seeburg PH, et al. (1996) A mammalian RNA editing enzyme. Nature 379: 460-464.
5. O'Connell MA, Krause S, Higuchi M, Hsuan JJ, Totty NF, et al. (1995) Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol Cell Biol 15: 1389-1397.
6. Maas S, Kawahara Y, Tamburro KM, Nishikura K (2006) A-to-I RNA editing and human disease. RNA Biol 3: 1-9.
7. Keegan LP, Leroy A, Sproul D, O'Connell MA (2004) Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes. Genome Biol 5: 209.
8. Li JB, Levanon EY, Yoon JK, Aach J, Xie B, et al. (2009) Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 324: 1210-1213.
9. Athanasiadis A, Rich A, Maas S (2004) Widespread A-to-I RNA Editing of Alu-Containing mRNAs in the Human Transcriptome. PLoS Biol 2: e391. 10.1371/journal.pbio.0020391.
10. Blow M, Futreal PA, Wooster R, Stratton MR (2004) A survey of RNA editing in human brain. Genome Res 14: 2379-2387.
11. Kim DD, Kim TT, Walsh T, Kobayashi Y, Matise TC, et al. (2004) Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res 14: 1719-1725.
12. Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, et al. (2004) Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 22: 1001-1005.
13. Conticello SG (2008) The AID/APOBEC family of nucleic acid mutators. Genome Biol 9: 229.
14. Navaratnam N, Morrison JR, Bhattacharya S, Patel D, Funahashi T, et al. (1993) The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem 268: 20709-20712.
15. Teng B, Burant CF, Davidson NO (1993) Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260: 1816-1819.
16. Harris RS, Petersen-Mahrt SK, Neuberger MS (2002) RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell 10: 1247-1253.
17. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, et al. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274: 18470-18476.
18. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
19. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, et al. (2000) Activationinduced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
20. Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, et al. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79: 285-296.
21. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
22. Wedekind JE, Dance GS, Sowden MP, Smith HC (2003) Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet 19: 207-216.
23. Mehta A, Kinter MT, Sherman NE, Driscoll DM (2000) Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol 20: 1846-1854.
24. Lellek H, Kirsten R, Diehl I, Apostel F, Buck F, et al. (2000) Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J Biol Chem 275: 19848-19856.
25. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809.
26. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103.
27. Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, et al. (2003) Speciesspecific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114: 21-31.
28. Vartanian JP, Guetard D, Henry M, Wain-Hobson S (2008) Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320: 230-233.
29. Yu Q, Konig R, Pillai S, Chiles K, Kearney M, et al. (2004) Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol 11: 435-442.
30. Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, et al. (2005) APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433: 430-433.
31. Chiu YL, Greene WC (2008) The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 26: 317-353.
32. Ewing B, Green P (1998) Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8: 186-194.
33. Ewing B, Hillier L, Wendl MC, Green P (1998) Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8: 175-185.
34. Lee YN, Malim MH, Bieniasz PD (2008) Hypermutation of an ancient human retrovirus by APOBEC3G. J Virol 82: 8762-8770.
35. Chiu YL, Witkowska HE, Hall SC, Santiago M, Soros VB, et al. (2006) Highmolecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci U S A 103: 15588-15593.
36. Lehmann KA, Bass BL (2000) Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 39: 12875-12884.
37. Wong SK, Sato S, Lazinski DW (2001) Substrate recognition by ADAR1 and ADAR2. Rna 7: 846-858.
38. Hillier LD, Lennon G, Becker M, Bonaldo MF, Chiapelli B, et al. (1996) Generation and analysis of 280,000 human expressed sequence tags. Genome Res 6: 807-828.
39. Eisenberg E, Nemzer S, Kinar Y, Sorek R, Rechavi G, et al. (2005) Is abundant A-to-I RNA editing primate-specific? Trends Genet 21: 77-81.
40. Neeman Y, Levanon EY, Jantsch MF, Eisenberg E (2006) RNA editing level in the mouse is determined by the genomic repeat repertoire. Rna 12: 1802-1809.
41. Bass BL, Weintraub H (1987) A developmentally regulated activity that unwinds RNA duplexes. Cell 48: 607-613.
42. Scadden AD (2007) Inosine-containing dsRNA binds a stress-granule-like complex and downregulates gene expression in trans. Mol Cell 28: 491-500.
43. Kimelman D, Kirschner MW (1989) An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes. Cell 59: 687-696.
44. Saccomanno L, Bass BL (1999) A minor fraction of basic fibroblast growth factor mRNA is deaminated in Xenopus stage VI and matured oocytes. Rna 5: 39-48.
45. Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VA, et al. (2005) Fine-scale structural variation of the human genome. Nat Genet 37: 727-732.
46. McKernan KJ, Peckham HE, Costa GL, McLaughlin SF, Fu Y, et al. (2009) Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Res.
47. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, et al. (2008) Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456: 53-59.
48. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, et al. (2008) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 36: D13-21.
49. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12: 996-1006.
50. Zhang Z, Schwartz S, Wagner L, Miller W (2000) A greedy algorithm for aligning DNA sequences. J Comput Biol 7: 203-214.
51. Zaranek A, Clegg T, Vandewege W, Church G. Free Factories: Unified Infrastructure for Data Intensive Web Services; 2008. Boston, MA. pp 391-404.